In addition, we confirmed that anti-PD-L1 antibody could produce the similar effects in reducing release of NETs and enhancing autophagy in human neutrophils from ARDS patients, which indicates the therapeutic effect of anti-PD-L1 antibody against ARDS and brings a new direction to the treatment of ARDS. Here, CD274 is linked to acute respiratory distress syndrome.